Alejandro Oviedo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alejandro Oviedo has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Alexander P. Vasilakopoulos
Department of Biochemistry, Emory University School of Medicine, 1510 Clifton Road NE, Atlanta, GA 30322, USA
2 shared publications - Camden R. Bair
Department of Microbiology and Immunology, Emory University School of Medicine, 1510 Clifton Road NE, Atlanta, GA 30322, USA
2 shared publications - David VanInsberghe
Department of Microbiology and Immunology, Emory University School of Medicine, 1510 Clifton Road NE, Atlanta, GA 30322, USA
2 shared publications - Graeme Leslie Conn
Department of Biochemistry, Emory University School of Medicine , Atlanta, GA 30322
2 shared publications - Kierra Regis
Department of Biochemistry, Emory University School of Medicine, 1510 Clifton Road NE, Atlanta, GA 30322, USA
2 shared publications - Alexander Kornienko
Texas State University
1 shared publication
Latest Publications
- Open Access
- 25 May 2026
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (7) , 113194
SARS-CoV-2 5′-UTR stem-loops activate the antiviral protein oligoadenylate synthetase 1 (OAS1)
- 25 May 2026
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (7) , 113194
Open AccessSARS-CoV-2 5′-UTR stem-loops activate the antiviral protein oligoadenylate synthetase 1 (OAS1)
- Open Access
SARS-CoV-2 5’-UTR stem-loops activate the antiviral protein oligoadenylate synthetase 1 (OAS1)
The innate immune system relies on pathogen recognition receptors, such as the 2’,5’-oligoadenylate synthetase (OAS) proteins, to detect pathogen-associated molecular patterns like viral double-stranded (ds)RNA. A specific splicing variant of OAS1 (OAS1-p46) has been implicated in initiating an immune response that leads to decreased disease severity during SARS-CoV-2 infection. OAS1-p46 has a C-terminal lipid modification motif that allows for anchoring of the protein to intracellular membranes and thus potential colocalization with immunogenic viral RNA regions such as the SARS-CoV-2 5’-untranslated region (5’-UTR). Here, we show that OAS proteins can detect the 5’-structured elements (5’-SE)–comprising the 5’-UTR and three additional stem-loop structures–and activate the cellular RNase L pathway. Through systematic 3’-end truncations of the 5’-SE, we show that the smallest 5’-SE fragment capable of potently activating OAS1 is the conserved and highly structured SL1-4b region, containing the first four stem-loop structures and their intervening linking sequences (SL1-4), as well as an unstructured region (“SL4b”) to the 3’-side of SL4. Analyses of OAS1 activation and RNA secondary structure probing using selective 2’-hydroxyl acylation analyzed by primer extension and mutational profiling (SHAPE-MaP) of additional SL1-4b RNA variants suggests a model in which SL4 acts as the primary OAS1 interaction site, while the unstructured SL4b region and two other stem-loops (SL1 and SL3) are necessary for optimal presentation of this region for OAS1 activation. Our findings reveal a structurally complex viral RNA region that potently activates OAS1, underscoring the potential complexity of RNAs that can strongly activate this innate immune sensor.
Open AccessSARS-CoV-2 5’-UTR stem-loops activate the antiviral protein oligoadenylate synthetase 1 (OAS1)
The innate immune system relies on pathogen recognition receptors, such as the 2’,5’-oligoadenylate synthetase (OAS) proteins, to detect pathogen-associated molecular patterns like viral double-stranded (ds)RNA. A specific splicing variant of OAS1 (OAS1-p46) has been implicated in initiating an immune response that leads to decreased disease severity during SARS-CoV-2 infection. OAS1-p46 has a C-terminal lipid modification motif that allows for anchoring of the protein to intracellular membranes and thus potential colocalization with immunogenic viral RNA regions such as the SARS-CoV-2 5’-untranslated region (5’-UTR). Here, we show that OAS proteins can detect the 5’-structured elements (5’-SE)–comprising the 5’-UTR and three additional stem-loop structures–and activate the cellular RNase L pathway. Through systematic 3’-end truncations of the 5’-SE, we show that the smallest 5’-SE fragment capable of potently activating OAS1 is the conserved and highly structured SL1-4b region, containing the first four stem-loop structures and their intervening linking sequences (SL1-4), as well as an unstructured region (“SL4b”) to the 3’-side of SL4. Analyses of OAS1 activation and RNA secondary structure probing using selective 2’-hydroxyl acylation analyzed by primer extension and mutational profiling (SHAPE-MaP) of additional SL1-4b RNA variants suggests a model in which SL4 acts as the primary OAS1 interaction site, while the unstructured SL4b region and two other stem-loops (SL1 and SL3) are necessary for optimal presentation of this region for OAS1 activation. Our findings reveal a structurally complex viral RNA region that potently activates OAS1, underscoring the potential complexity of RNAs that can strongly activate this innate immune sensor.
- 18 August 2023
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 94, 129455
Discovery of 5-sulfonyltetrazoles as neuroblastoma differentiation agents
- 18 August 2023
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 94, 129455
Discovery of 5-sulfonyltetrazoles as neuroblastoma differentiation agents